In contrast to prior findings that MMF [36], but not CYC, therapy [37] is associated with severe hypogammaglobulinemia, we observed a significant decline of IgG and IgM after CYC, but only of IgM after MMF was initiated. This evidence concerns the gene CD40LG and Decreased circulating immunoglobulin concentration.